<DOC>
	<DOC>NCT02005601</DOC>
	<brief_summary>We are investigating the impact of duloxetine ("Cymbalta"), a serotonin and norepinephrine reuptake inhibitor, on pain after total knee arthroplasty (TKA). Specifically, the investigators will determine whether duloxetine, 60 mg daily for 2 weeks, reduces pain scores 2 weeks after TKA.</brief_summary>
	<brief_title>Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty?</brief_title>
	<detailed_description />
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Patients with osteoarthritis scheduled for primary tricompartmental total knee arthroplasty with a participating surgeon Age 25 to 75 years Planned use of regional anesthesia Ability to follow study protocol English speaking (primary outcome obtained via telephone call and secondary outcomes include questionnaires validated in English only) Patients planning on being discharged home or to a rehabilitation center that has agreed to participate Concurrent use of duloxetine or other SNRIs, MAOIs, Tricyclic antidepressants, triptans (sumatriptan, rizatriptan, naratriptan, zolmitriptan, eletriptan, almotriptan, frovatriptan), lithium, buspirone, St. John's Wort Hepatic insufficiency Renal insufficiency Patients younger than 25 years old and older than 75 Patients intending to receive general anesthesia Allergy or intolerance to one of the study medications Patients with an ASA of IV Chronic gabapentin/pregabalin use (regular use for longer than 3 months) Chronic opioid use (taking opioids for longer than 3 months) Patients with major prior ipsilateral open knee surgery</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>